JP2016539190A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539190A5
JP2016539190A5 JP2016554939A JP2016554939A JP2016539190A5 JP 2016539190 A5 JP2016539190 A5 JP 2016539190A5 JP 2016554939 A JP2016554939 A JP 2016554939A JP 2016554939 A JP2016554939 A JP 2016554939A JP 2016539190 A5 JP2016539190 A5 JP 2016539190A5
Authority
JP
Japan
Prior art keywords
polypeptide
formula
group
heteroarylene
alkenylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016554939A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539190A (ja
JP6609563B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/066300 external-priority patent/WO2015079376A1/en
Publication of JP2016539190A publication Critical patent/JP2016539190A/ja
Publication of JP2016539190A5 publication Critical patent/JP2016539190A5/ja
Application granted granted Critical
Publication of JP6609563B2 publication Critical patent/JP6609563B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016554939A 2013-11-26 2014-11-24 ケトンで修飾されたポリペプチドをオキシム複合化する方法 Expired - Fee Related JP6609563B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361909236P 2013-11-26 2013-11-26
US61/909,236 2013-11-26
US201462002614P 2014-05-23 2014-05-23
US62/002,614 2014-05-23
PCT/IB2014/066300 WO2015079376A1 (en) 2013-11-26 2014-11-24 Methods for oxime conjugation to ketone-modified polypeptides

Publications (3)

Publication Number Publication Date
JP2016539190A JP2016539190A (ja) 2016-12-15
JP2016539190A5 true JP2016539190A5 (https=) 2018-01-18
JP6609563B2 JP6609563B2 (ja) 2019-11-20

Family

ID=52117931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016554939A Expired - Fee Related JP6609563B2 (ja) 2013-11-26 2014-11-24 ケトンで修飾されたポリペプチドをオキシム複合化する方法

Country Status (15)

Country Link
US (1) US10172948B2 (https=)
EP (1) EP3074048B1 (https=)
JP (1) JP6609563B2 (https=)
KR (1) KR20160088429A (https=)
CN (1) CN105764530B (https=)
AU (1) AU2014356126B2 (https=)
CA (1) CA2928087A1 (https=)
EA (1) EA201691075A1 (https=)
ES (1) ES2729643T3 (https=)
IL (1) IL245244A0 (https=)
MX (1) MX2016006674A (https=)
TW (1) TWI572361B (https=)
UY (1) UY35854A (https=)
WO (1) WO2015079376A1 (https=)
ZA (1) ZA201602603B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2732574T3 (es) 2012-11-30 2019-11-25 Novartis Ag Métodos para preparar conjugados a partir de proteínas que contienen disulfuro
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
TW201609152A (zh) 2014-09-03 2016-03-16 免疫原公司 包含細胞結合劑及細胞毒性劑之偶聯物
EP3310813A1 (en) 2015-06-17 2018-04-25 Novartis AG Antibody drug conjugates
WO2017051254A1 (en) * 2015-09-25 2017-03-30 Legochem Biosciences, Inc. Compositions and methods related to anti-egfr antibody drug conjugates
CN108136043B (zh) 2015-10-01 2022-09-06 诺和诺德股份有限公司 蛋白质缀合物
TN2018000112A1 (en) 2015-10-29 2019-10-04 Novartis Ag Antibody conjugates comprising toll-like receptor agonist
HRP20240795T1 (hr) 2015-11-25 2024-09-13 Ligachem Biosciences Inc. Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima
KR102847350B1 (ko) 2015-11-25 2025-08-19 주식회사 리가켐바이오사이언스 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법
KR102468989B1 (ko) * 2016-11-18 2022-11-22 가고시마 유니버시티 IgG 결합 펩타이드를 포함하는 고상 담체 및 IgG의 분리 방법
MX2019011655A (es) 2017-03-29 2019-12-19 Legochem Biosciences Inc Profarmaco de dimero de pirrolobenzodiazepina y compuesto conjugado ligando-conector de este.
AR111651A1 (es) 2017-04-28 2019-08-07 Novartis Ag Conjugados de anticuerpos que comprenden agonistas del receptor de tipo toll y terapias de combinación
JP7459063B2 (ja) 2018-05-09 2024-04-01 レゴケム バイオサイエンシズ, インク. 抗-cd19抗体薬物複合体に関連する組成物および方法
US12391939B2 (en) 2018-07-23 2025-08-19 The Governors Of The University Of Alberta Genetically-encoded bicyclic peptide libraries
SG11202104652SA (en) * 2018-11-28 2021-06-29 Univ Alberta Genetically-encoded macrocyclic peptide libraries bearing a pharmacophore
KR20210028544A (ko) 2019-09-04 2021-03-12 주식회사 레고켐 바이오사이언스 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239110B1 (en) 1990-02-22 2001-05-29 W.R. Grace & Co. -Conn. Synthetic analogs of thrombospondin and therapeutic use thereof
WO1999013063A1 (en) 1997-09-09 1999-03-18 Nycomed Imaging As Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
WO1999013062A1 (en) 1997-09-09 1999-03-18 Nycomed Imaging As Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
GB0316294D0 (en) 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
US8673848B2 (en) 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
WO2008157380A2 (en) 2007-06-15 2008-12-24 Adherex Technologies Inc. Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses therefor
WO2010025510A1 (en) 2008-09-03 2010-03-11 Xenome Ltd Libraries of peptide conjugates and methods for making them
JP5954789B2 (ja) 2009-08-10 2016-07-20 ユーシーエル ビジネス パブリック リミテッド カンパニー 機能的分子の可逆的共有結合
WO2014059028A1 (en) 2012-10-09 2014-04-17 Igenica, Inc. Anti-c16orf54 antibodies and methods of use thereof
CA2891261C (en) 2012-11-15 2023-04-04 Brandeis University Tethering cysteine residues using cyclic disulfides
ES2732574T3 (es) * 2012-11-30 2019-11-25 Novartis Ag Métodos para preparar conjugados a partir de proteínas que contienen disulfuro

Similar Documents

Publication Publication Date Title
JP2016539190A5 (https=)
JP2018509394A5 (https=)
US20230131121A1 (en) Branched discrete peg constructs
CN112261954B (zh) 具有针对抗体的亲和性物质和生物正交性官能团的化合物或其盐
JP2021527040A (ja) カンプトテシンコンジュゲート
RU2015119561A (ru) Новые конъюгаты лекарственное вещество-белок
JP2020531466A (ja) 免疫刺激物質トル様受容体7(tlr7)アゴニストとしての6−アミノ−7,9−ジヒドロ−8h−プリン−8−オン誘導体
JP6609563B2 (ja) ケトンで修飾されたポリペプチドをオキシム複合化する方法
JP2017503011A5 (https=)
JP2016512425A5 (https=)
TW201920183A (zh) 具有三環部分之類鐸受體7(tlr7)促效劑、其結合物及其方法及用途
EP3668869A1 (en) 6-amino-7,9-dihydro-8h-purin-8-one derivatives as toll-like receptor 7 (tlr7) agonists as immunostimulants
JP2019043957A5 (https=)
RU2015146614A (ru) Конъюгированная вакцина на основе пептида антигена wt1
JP2012518029A5 (https=)
JP2017504606A5 (https=)
TW201920180A (zh) 具苯并三唑部分之類鐸受體7(tlr7)促效劑,其結合物及其方法及用途
JP2018510864A5 (https=)
JP2023010733A (ja) γ-アマニチンの誘導体
JP2016153410A5 (https=)
WO2015118031A2 (en) Antibody-drug conjugates and immunotoxins
JP2014516991A5 (https=)
CA2653941A1 (en) Substituted amino purine derivatives and uses thereof
WO2015118030A2 (en) Antibody-drug conjugates and immunotoxins
JP2020506685A5 (https=)